The largest database of trusted experimental protocols

Dynabeads flowcomp human cd4 kit

Manufactured by Thermo Fisher Scientific

The Dynabeads™ FlowComp™ Human CD4 Kit is a lab equipment product designed for the isolation of CD4-positive T cells from human blood or cell samples. The kit utilizes magnetic beads coated with antibodies specific to the CD4 antigen, allowing for the efficient separation and enrichment of CD4-positive cells from the sample.

Automatically generated - may contain errors

4 protocols using dynabeads flowcomp human cd4 kit

1

Analyzing Immune Response in Acute Ischemic Stroke

Check if the same lab product or an alternative is used in the 5 most similar protocols
After recruitment, basic characteristics of AIS patients were documented for analysis, including demographic information and underlying disease. National Institute of Health stroke scale (NIHSS) score was evaluated on the day of admission, which was used for disease severity assessment.16 Peripheral blood samples of AIS patients were also collected on the day of admission, which were divided into two parts: one was processed by centrifugalizing to separate serum samples for measurement of interleukin‐6 (IL‐6), interleukin‐17 (IL‐17), and intercellular cell adhesion molecule‐1 (ICAM1); the other was treated with Dynabeads™ FlowComp™ Human CD4 Kit (Invitrogen) to isolate CD4+ T cells from blood samples according to the manufacturer's instructions. After isolating CD4+ T cells, the Th17 cell ratio in the CD4+ T cells was measured immediately by flow cytometry. The total RNA in CD4+ T cells was extracted using TRIzol™ Reagent (Invitrogen) and stored at −80℃ for lncRNA UCA1 detection.
+ Open protocol
+ Expand
2

Quantifying Cell-associated HIV-1 Proviral DNA and RNA

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell-associated HIV-1 proviral DNA was measured at baseline and week 4, and cell-associated HIV-1 RNA was measured at each visit through week 16 (baseline, days 2, 4, 8, week 4 and 16). CD4+T cells were isolated from PBMCs using Dynabeads FlowComp Human CD4 Kit (Invitrogen). DNA and RNA isolation was performed with AllPrep DNA/RNA Mini Kit (Qiagen). Isolated RNA was treated with DNase I, Amplification Grade (Invitrogen) and purified with RNeasy Mini Kit (Qiagen). Real time PCR was performed with AmpliTaq Gold with Buffer A or AmpliTaq Gold DNA Polymerase with Buffer II and MgCl2 with ROX Reference Dye (Applied Biosystems) using the Stratagene Mx3000P QPCR System (Agilent Technologies). PCR reactions were performed in quadruplicate. Note that for each case an optimal primers/probe set was determined, which gave the highest amplification efficiency among three primer/probe sets tested. Accordingly two primer/probe sets were used, RF/RR/PB (41 (link)) for 9 participants and 6F/84R/HIV gag probe (42 (link)) for 6 participants.
Cell-associated RNA was primed with random hexamers and reverse transcribed with Superscript II (Invitrogen). PCR reagent mix containing primers, probe, and AmpliTaq Gold was added to each of RT product, and quantitative rtPCR was performed as described above in quadruplicate. No reverse transcriptase control was also included.
+ Open protocol
+ Expand
3

Minocycline Modulation of CD4+ T Cell Activation

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD4+ T cells were isolated from PBMCs by the Dynabeads FlowComp Human CD4 kit (Invitrogen). Purity was consistently >95% of live cells as determined by CD3 and CD4 staining by flow cytometry. CD4+ T cells were grown in 96-well plates or anti-CD3 coated 96-well plates (BD) with or without 20 μM minocycline hydrochloride (Sigma) in 100 μl RPMI 1640 supplemented with 10% FBS, 2 mM L-glutamine, 1 mM HEPES buffer, and 2 mg/mL gentamicin. After 24 hours, a 50 μL aliquot containing 60 μM minocycline was added to replenish minocycline at a final concentration of 20 μM in the 150 μL well volume. Some wells were also stimulated with 1,000 U/mL each of IFNα-2a and IFNβ-1a (PBL). All wells had a final volume of 150 μL and were cultured for an additional 24 hours (total 48 hours) before flow cytometry analysis.
+ Open protocol
+ Expand
4

Characterizing AIS Patients and Controls

Check if the same lab product or an alternative is used in the 5 most similar protocols
Clinical characteristics of AIS patients and controls were documented after enrollment, which included age, gender, body mass index (BMI), current smoking status, and comorbidities. For AIS patients, the National Institutes of Health Stroke Scale (NIHSS) score was assessed on the day of admission for the assessment of disease severity. In addition, peripheral blood samples of AIS patients (on the day of admission) and controls were collected; meanwhile, the peripheral blood mononuclear cells (PBMCs) and the serum samples were collected by density gradient centrifugation. The CD4+ T cells were isolated from the PBCMs using a Dynabeads® FlowComp™ Human CD4 kit (Invitrogen) following the protocol given by the manufacturer.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!